Miyuki Nakagawa Selected Research

Miyuki Nakagawa Research Topics

3	Neoplasms (Cancer) 09/2022 - 04/2020
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2021
1	Liver Neoplasms (Liver Cancer) 09/2022
1	Microsatellite Instability 11/2021
1	Carcinoma (Carcinomatosis) 04/2020
1	Sensorineural Hearing Loss 01/2020
1	Abdominal Pain (Pain, Abdominal) 11/2019
1	Wounds and Injuries (Trauma) 11/2019
1	Hematoma 11/2019
1	Pulmonary Hypertension 11/2019
1	Infections 08/2005
1	Bacterial Infections (Bacterial Infection) 08/2005
1	Fetal Death 12/2004

2	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 11/2021
1	Biomarkers (Surrogate Marker)IBA 09/2022
1	GelatinIBA 09/2022
1	atezolizumabIBA 01/2022
1	durvalumabIBA 01/2022
1	tremelimumabIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	pembrolizumabIBA 11/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Warfarin (Coumadin)FDA LinkGeneric 11/2019
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2005
1	Ceftazidime (Fortum)FDA LinkGeneric 08/2005
1	tomopenemIBA 08/2005
1	Meropenem (Merrem)FDA LinkGeneric 08/2005
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 08/2005
1	Vancomycin FDA LinkGeneric 08/2005
1	Polychlorinated Dibenzodioxins (TCDD)IBA 12/2004
1	InterferonsIBA 12/2004